Deficiency of neutrophil high-mobility group box protein-1, in liver transplant recipients, exacerbates early allograft injury in mice
Zhuolun Song,Hui Han,Xiaodong Ge,Sukanta Das,Romain Desert,Dipti Athavale,Wei Chen,Sai Santosh Babu Komakula,Daniel Lantvit,Natalia Nieto
DOI: https://doi.org/10.1097/hep.0000000000000346
IF: 17.298
2023-04-06
Hepatology
Abstract:BACKGROUND AIMS: Early allograft dysfunction (EAD) is a severe event, leading to graft failure after liver transplant (LT). Extracellular high-mobility group box-1 (HMGB1) is a damage-associated molecular pattern (DAMP) that contributes to hepatic ischemia-reperfusion injury (IRI). However, the contribution of intracellular HMGB1 to LT graft injury, remains elusive. We hypothesized that intracellular neutrophil-derived HMGB1 from recipients, protects from post-LT EAD.APPROACH RESULTS: We generated mice with conditional ablation or overexpression of Hmgb1 in hepatocytes, myeloid cells, or both. We performed LTs and injected lipopolysaccharide (LPS) to evaluate the effect of intracellular HMGB1 in EAD. Ablation of Hmgb1 in hepatocytes and myeloid cells of donors and recipients, exacerbated early allograft injury after LT. Ablation of Hmgb1 from liver grafts, did not affect graft injury; however, lack of Hmgb1 from recipient myeloid cells, increased reactive oxygen species (ROS) and inflammation in liver grafts, and exacerbated injury. Neutrophils lacking HMGB1 were more activated, showed enhanced pro-oxidant and pro-inflammatory signatures, and reduced biosynthesis and metabolism of inositol polyphosphates (InsPs). Upon LT reperfusion or LPS treatment, there was significant neutrophil mobilization and infiltration into the liver, and enhanced production of ROS and pro-inflammatory cytokines, when intracellular Hmgb1 was absent. Depletion of neutrophils using anti-Ly6G antibody (Ab), attenuated graft injury in recipients with myeloid cell Hmgb1 ablation.CONCLUSIONS: Neutrophil HMGB1 from recipients is central to regulate their activation, limiting production of ROS and pro-inflammatory cytokines, and protects from early liver allograft injury.
gastroenterology & hepatology